Monitoring of neuromodulation using biomarkers
US11338140B2 · kind B2 · utility
1Cited by
403References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 3, 2017 |
| Grant date | May 24, 2022 |
| Priority date | — |
| Expiry date | Apr 27, 2039 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/347
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Provided herein are methods, devices, compositions, and kits for monitoring neuromodulation efficacy based on changes in the level or activity of one or more target biomarkers. One aspect includes a comparison of baseline and post-modulation levels of one or more biomarkers in bodily fluid that have each been collected from a human subject at a relevant time, and that may be used to assess the neuromodulation efficacy. The post-neuromodulation levels for the one or more biomarkers may be collected from the human subject within about 5 minutes to about 14 days post-neuromodulation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.